An evaluation of a hybrid compact gamma camera to simplify the sentinel node procedure in breast cancer.

An evaluation of a hybrid compact gamma camera to simplify the sentinel node procedure in breast cancer. - Evaluation of a hybrid compact gamma camera

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42201

Enrollment

Registered

2015-04-09

Start date

2010-10-12

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymph Node Sentinel node

Interventions

Compact gamma camera

Mobile gamma camera

Sentinel node

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Woman - Proven breast cancer - Scheduled for SN procedure - De patient must be able to provide *informed consent*

Exclusion criteria

Exclusion criteria: Other radionuclides which could influence the procedure. (This does not apply for a ROLL procedure with Tc-99m MAA or Nanocolloid or an I-125 seed)

Design outcomes

Primary

Measure	Time frame
The primary outcome criterion is the difference in detection rate between planar scintigraphy and the hybrid GCG.	—

Secondary

Measure	Time frame
- The incremental value of the hybrid CGC in assisting in surgery for SN detection next to the gamma probe. - A subjective outcome describing the additional value of the hybrid aspect of this camera. - The feasibility to localise I-125 seeds in breast cancer surgery.	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)